Effect of intermittent dosing regimens of erlotinib on methylnitrosourea- induced mammary carcinogenesis
Ronald A. Lubet, Eva Szabo, Kenneth K. Iwata, Stanley C. Gill, Chris Tucker, Ann Bode, Vernon E. Steele, M. Margaret Juliana, Holly L. Nicastro, Clinton J. Grubbs
Dive into the research topics of 'Effect of intermittent dosing regimens of erlotinib on methylnitrosourea- induced mammary carcinogenesis'. Together they form a unique fingerprint.